BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32757426)

  • 1. The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification.
    Colecchia M; Bertolotti A; Paolini B; Giunchi F; Necchi A; Paganoni AM; Ricci C; Fiorentino M; Dagrada GP
    Histopathology; 2021 Jan; 78(2):290-299. PubMed ID: 32757426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features.
    Rizzo NM; Sholl LM; Idrees MT; Cheville JC; Gupta S; Cornejo KM; Miyamoto H; Hirsch MS; Collins K; Acosta AM
    Mod Pathol; 2021 Oct; 34(10):1935-1946. PubMed ID: 34103665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
    Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
    Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leydig cell tumors of the testis with unusual features: adipose differentiation, calcification with ossification, and spindle-shaped tumor cells.
    Ulbright TM; Srigley JR; Hatzianastassiou DK; Young RH
    Am J Surg Pathol; 2002 Nov; 26(11):1424-33. PubMed ID: 12409718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leydig cell tumor: a report of two cases with unusual presentation.
    Sengupta S; Chatterjee U; Sarkar K; Chatterjee S; Kundu A
    Indian J Pathol Microbiol; 2010; 53(4):796-8. PubMed ID: 21045421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study on contrast-enhanced magnetic resonance imaging of testicular lesions: distinctive features of Leydig cell tumours.
    Manganaro L; Vinci V; Pozza C; Saldari M; Gianfrilli D; Pofi R; Bernardo S; Cantisani V; Lenzi A; Scialpi M; Catalano C; Isidori AM
    Eur Radiol; 2015 Dec; 25(12):3586-95. PubMed ID: 25981218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study.
    Pozza C; Pofi R; Tenuta M; Tarsitano MG; Sbardella E; Fattorini G; Cantisani V; Lenzi A; Isidori AM; Gianfrilli D;
    Hum Reprod; 2019 Aug; 34(8):1389-1403. PubMed ID: 31532522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leydig-cell tumour of the testis: retrospective analysis of clinical and therapeutic features in 204 cases.
    Ruf CG; Sanatgar N; Isbarn H; Ruf B; Simon J; Fankhauser CD; Dieckmann KP
    World J Urol; 2020 Nov; 38(11):2857-2862. PubMed ID: 31960106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metachronous development of malignant Leydig cell tumor.
    Sugimura J; Suzuki Y; Tamura G; Funaki H; Fujioka T; Satodate R
    Hum Pathol; 1997 Nov; 28(11):1318-20. PubMed ID: 9385943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.
    Lyle PL; Bridge JA; Simpson JF; Cates JM; Sanders ME
    Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
    Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular proliferation and nuclear ploidy assessments augment established prognostic factors in predicting malignancy in testicular Leydig cell tumours.
    McCluggage WG; Shanks JH; Arthur K; Banerjee SS
    Histopathology; 1998 Oct; 33(4):361-8. PubMed ID: 9822927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.
    Limbach AL; Lingen MW; McElherne J; Mashek H; Fitzpatrick C; Hyjek E; Mostofi R; Cipriani NA
    Head Neck Pathol; 2020 Dec; 14(4):889-898. PubMed ID: 32026294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced ultrasound and real-time elastography for the diagnosis of benign Leydig cell tumors of the testis - a single center report on 13 cases.
    Lock G; Schröder C; Schmidt C; Anheuser P; Loening T; Dieckmann KP
    Ultraschall Med; 2014 Dec; 35(6):534-9. PubMed ID: 25140496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
    Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
    Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors.
    Cheville JC; Sebo TJ; Lager DJ; Bostwick DG; Farrow GM
    Am J Surg Pathol; 1998 Nov; 22(11):1361-7. PubMed ID: 9808128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colour Doppler and ultrasound characteristics of testicular Leydig cell tumours.
    Maxwell F; Izard V; Ferlicot S; Rachas A; Correas JM; Benoit G; Bellin MF; Rocher L
    Br J Radiol; 2016 Jun; 89(1062):20160089. PubMed ID: 27072392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in-depth look at Leydig cell tumor of the testis.
    Al-Agha OM; Axiotis CA
    Arch Pathol Lab Med; 2007 Feb; 131(2):311-7. PubMed ID: 17284120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 cases.
    Ricciotti RW; Baraff AJ; Jour G; Kyriss M; Wu Y; Liu Y; Li SC; Hoch B; Liu YJ
    Cancer Genet; 2017 Dec; 218-219():69-80. PubMed ID: 29153098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous Liposarcomatous Differentiation in Malignant Phyllodes Tumor is Histologically Similar but Immunohistochemically and Molecularly Distinct from Well-differentiated Liposarcoma of Soft Tissue.
    Inyang A; Thomas DG; Jorns J
    Breast J; 2016 May; 22(3):282-6. PubMed ID: 26843318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.